Last Name,First Name,Email,Company,Department,City,State,Country,Postal Code,Lead Source,Publication Date,Publication Link,Publication Title
Mendez,Julio,,Yale University,Department of Anesthesiology,New Haven,CT,USA,06520,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Ghaedi,Mahboobe,,Yale University,Department of Anesthesiology,New Haven,CT,USA,06520,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Sivarapatna,Amogh,,Yale University,Department of Anesthesiology,New Haven,CT,USA,06520,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Dimitrievska,Sashka,,Yale University,Department of Anesthesiology,New Haven,CT,USA,06520,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Shao,Zhen,,,"Department of Chemical and Environmental Engineering, Yale University, New Haven, CT, USA",,,,,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Osuji,Chinedum,,,"Department of Chemical and Environmental Engineering, Yale University, New Haven, CT, USA",,,,,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Steinbacher,Derek,,,"Department of Surgery, Yale University School of Medicine, New Haven, CT, USA",,,,,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Leffell,David,,,"Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA",,,,,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Niklason,Laura,laura.niklason@yale.edu,Yale University,Department of Anesthesiology,New Haven,CT,USA,06520,Connexon,11/26/2014,http://dx.doi.org/10.1016/j.biomaterials.2014.11.011,Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo.
Krstic,Jelena,,University of Belgrade,Laboratory for Experimental Hematology and Stem Cells Institute for Medical Research,Dr Subotica 4,11129,Serbia,Belgrade,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Obradovic,Hristina,,University of Belgrade,Laboratory for Experimental Hematology and Stem Cells Institute for Medical Research,Dr Subotica 4,11129,Serbia,Belgrade,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Jaukovic,Aleksandra,,University of Belgrade,Laboratory for Experimental Hematology and Stem Cells Institute for Medical Research,Dr Subotica 4,11129,Serbia,Belgrade,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Dordevic,Ivana,,University of Belgrade,Laboratory for Experimental Hematology and Stem Cells Institute for Medical Research,Dr Subotica 4,11129,Serbia,Belgrade,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Trivanovic,Drenka,,University of Belgrade,Laboratory for Experimental Hematology and Stem Cells Institute for Medical Research,Dr Subotica 4,11129,Serbia,Belgrade,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Kukolj,Tamara,,University of Belgrade,Laboratory for Experimental Hematology and Stem Cells Institute for Medical Research,Dr Subotica 4,11129,Serbia,Belgrade,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Mojsilovic,Slavko,,University of Belgrade,Laboratory for Experimental Hematology and Stem Cells Institute for Medical Research,Dr Subotica 4,11129,Serbia,Belgrade,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Ilic,Vesna,,,"Laboratory for Immunology, Institute for Medical Research, University of Belgrade, Dr Subotica 4, 11129 Belgrade, Serbia",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Santibanez,Juan,jfsantibanez@imi.bg.ac.rs,University of Belgrade,Laboratory for Experimental Hematology and Stem Cells Institute for Medical Research,Dr Subotica 4,11129,Serbia,Belgrade,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Bugarski,Diana,,,Electronic address: jfsantibanez@imi.bg.ac.rs,,,,,Connexon,11/27/2014,http://dx.doi.org/10.1016/j.bbamcr.2014.11.025,Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Ming,Leiguo,,,"1] State Key Laboratory of Military Stomatology, Center for Tissue Engineering, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, China [2] State Key Laboratory of Military Stomatology, Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China [3] Institute forTissue Engineering and Regenerative Medicine Research of Xi'an, Xi'an, China",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Jin,Fang,,,"Department of Orthodontics, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi, China",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Huang,Ping,,,"Department of Clinical Laboratory, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Luo,Hailang,,,"710032, China",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Liu,Wenjia,,,"1] State Key Laboratory of Military Stomatology, Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China [2] Institute forTissue Engineering and Regenerative Medicine Research of Xi'an, Xi'an, China",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Zhang,Leilei,,,"1] Research and Development Center for Tissue Engineering, Fourth Military Medical University, Xi'an, Shaanxi 710032, China [2] State Key Laboratory of Military Stomatology, Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China [3] Institute forTissue Engineering and Regenerative Medicine Research of Xi'an, Xi'an, China",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Yuan,Wei,,,"1] State Key Laboratory of Military Stomatology, Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China [2] Institute forTissue Engineering and Regenerative Medicine Research of Xi'an, Xi'an, China",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Zhang,Yongjie,,,"1] State Key Laboratory of Military Stomatology, Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China [2] Institute forTissue Engineering and Regenerative Medicine Research of Xi'an, Xi'an, China",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Jin,Yan,,,"1] State Key Laboratory of Military Stomatology, Center for Tissue Engineering, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, China [2] Research and Development Center for Tissue Engineering, Fourth Military Medical University, Xi'an, Shaanxi 710032, China [3] State Key Laboratory of Military Stomatology, Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China",,,,,Connexon,11/27/2014,http://dx.doi.org/10.1038/srep07209,Licochalcone A up-regulates of FasL in mesenchymal stem cells to strengthen bone formation and increase bone mass.
Jeoung,Ji,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Nam,Hae,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Kwak,Jihye,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Jin,Hye,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Lee,Hyang,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Lee,Byoung,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Baek,Jonghyuk,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Eom,Jin,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Chang,Eun-Ju,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Shin,Dong-Myung,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Choi,Soo,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Kim,Seung,,,"University of Ulsan College of Medicine, Department of Biochemistry and Molecular Biology, Seoul, Korea, Republic of ; bigimsae@naver.com.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1089/scd.2014.0273,A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
Llufriu,Sara,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Sepulveda,Maria,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Blanco,Yolanda,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Marin,Pedro,,,"Hemotherapy Service, CDB, Hospital Clinic, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Moreno,Beatriz,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Berenguer,Joan,,,"Service of Neurorradiology, Hospital Clinic and Institut d'Investigacio Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Gabilondo,Inigo,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Martinez-Heras,Eloy,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Sola-Valls,Nuria,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Arnaiz,Joan-Albert,,,"Department of Clinical Pharmacology, Hospital Clinic, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Andreu,Enrique,,,"Cell Therapy Area, Clinica Universitaria de Navarra, Pamplona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Fernandez,Begona,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Bullich,Santi,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Sanchez-Dalmau,Bernardo,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Service of Ophtalmology, Hospital Clinic, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Graus,Francesc,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Villoslada,Pablo,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Saiz,Albert,,,"Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0113936,Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Coutu,Daniel,,,"Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0111966,Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix.
Mahfouz,Wally,,,"Department of Urology, Jewish General Hospital, McGill University, Montreal, Canada; Department of Urology, Alexandria University, Alexandria, Egypt",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0111966,Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix.
Loutochin,Oleg,,,"Department of Urology, Jewish General Hospital, McGill University, Montreal, Canada",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0111966,Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix.
Galipeau,Jacques,,,"Department of Hematology and Medical Oncology, Pediatrics & Medicine, Emory University, Atlanta, Georgia, United States of America",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0111966,Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix.
Corcos,Jacques,,,"Department of Urology, Jewish General Hospital, McGill University, Montreal, Canada.",,,,,Connexon,12/01/2014,http://dx.doi.org/10.1371/journal.pone.0111966,Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix.
Tewari,Deepshikha,,,"Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, B.S",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Khan,Mohd,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Sagar,Nitin,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
China,Shyamsundar,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Singh,Atul,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Kheruka,Subhash,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Barai,Sukanta,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Tewari,Mahesh,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Nagar,Geet,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Vishwakarma,Achchhe,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Ogechukwu,Omeje,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Bellare,Jayesh,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Gambhir,Sanjay,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Chattopadhyay,Naibedya,,,"10/1, Sector-10, Jankipuram Extension, Lucknow, India.",,,,,Connexon,11/30/2014,http://dx.doi.org/10.1007/s12015-014-9573-5,"Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site."
Razavi,Shahnaz,,,"Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1002/cbf.3074,Effect of T hormone on neural differentiation of human adipose derived stem cells.
Mostafavi,Fatemeh,,,"Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1002/cbf.3074,Effect of T hormone on neural differentiation of human adipose derived stem cells.
Mardani,Mohammad,,,"Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1002/cbf.3074,Effect of T hormone on neural differentiation of human adipose derived stem cells.
Zarkesh Esfahani,Hamid,,,"Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1002/cbf.3074,Effect of T hormone on neural differentiation of human adipose derived stem cells.
Kazemi,Mohammad,,,"Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1002/cbf.3074,Effect of T hormone on neural differentiation of human adipose derived stem cells.
Esfandiari,Ebrahim,,,"Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1002/cbf.3074,Effect of T hormone on neural differentiation of human adipose derived stem cells.
Guo,Peng,,,"Department of Orthopaedic Surgery, The Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1111/os.12135,Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein-2-induced Differentiation of Mesenchymal Stem Cells.
Shi,Zhong-Li,,,"Department of Orthopaedic Surgery, The Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1111/os.12135,Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein-2-induced Differentiation of Mesenchymal Stem Cells.
Liu,An,,,"Department of Orthopaedic Surgery, The Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1111/os.12135,Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein-2-induced Differentiation of Mesenchymal Stem Cells.
Lin,Tiao,,,"Department of Orthopaedic Surgery, The Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1111/os.12135,Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein-2-induced Differentiation of Mesenchymal Stem Cells.
Bi,Fanggang,,,"Department of Orthopaedic Surgery, The Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1111/os.12135,Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein-2-induced Differentiation of Mesenchymal Stem Cells.
Shi,Mingmin,,,"Department of Orthopaedic Surgery, The Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1111/os.12135,Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein-2-induced Differentiation of Mesenchymal Stem Cells.
Yan,Shi-Gui,,,"Department of Orthopaedic Surgery, The Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.",,,,,Connexon,11/28/2014,http://dx.doi.org/10.1111/os.12135,Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein-2-induced Differentiation of Mesenchymal Stem Cells.
Burk,Janina,burk@rz.uni-leipzig.de,University of Leipzig,Translational Centre for Regenerative Medicine (TRM),Philipp-Rosenthal-Strasse 55,04103,Germany,Leipzig,Connexon,11/20/2014,http://dx.doi.org/10.1186/1756-0500-7-826,Gene expression of tendon markers in mesenchymal stromal cells derived from different sources.
Gittel,Claudia,,,burk@rz.uni-leipzig.de.,,,,,Connexon,11/20/2014,http://dx.doi.org/10.1186/1756-0500-7-826,Gene expression of tendon markers in mesenchymal stromal cells derived from different sources.
Heller,Sandra,,,burk@rz.uni-leipzig.de.,,,,,Connexon,11/20/2014,http://dx.doi.org/10.1186/1756-0500-7-826,Gene expression of tendon markers in mesenchymal stromal cells derived from different sources.
Pfeiffer,Bastian,,,burk@rz.uni-leipzig.de.,,,,,Connexon,11/20/2014,http://dx.doi.org/10.1186/1756-0500-7-826,Gene expression of tendon markers in mesenchymal stromal cells derived from different sources.
Paebst,Felicitas,,,burk@rz.uni-leipzig.de.,,,,,Connexon,11/20/2014,http://dx.doi.org/10.1186/1756-0500-7-826,Gene expression of tendon markers in mesenchymal stromal cells derived from different sources.
Ahrberg,Annette,,,burk@rz.uni-leipzig.de.,,,,,Connexon,11/20/2014,http://dx.doi.org/10.1186/1756-0500-7-826,Gene expression of tendon markers in mesenchymal stromal cells derived from different sources.
Brehm,Walter,,,burk@rz.uni-leipzig.de.,,,,,Connexon,11/20/2014,http://dx.doi.org/10.1186/1756-0500-7-826,Gene expression of tendon markers in mesenchymal stromal cells derived from different sources.
